Abstract

CLOSURE OF A secundum atrial septal defect (ASD) or a patent foramen ovale (PFO) using a percutaneously deployed transcatheter occlusion device has emerged as a safe, less invasive, and widely accepted alterative to open surgical repair of these common congenital heart defects in adults 1 Chessa M. Carminati M. Butera G. et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002; 39: 1061-1065 Abstract Full Text Full Text PDF PubMed Scopus (497) Google Scholar , 2 Krumsdorf U. Ostermayer S. Billinger K. et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol. 2004; 43: 302-309 Abstract Full Text Full Text PDF PubMed Scopus (485) Google Scholar and children. 3 Butera G. De Rosa G. Chessa M. et al. Transcatheter closure of atrial septal defect in young children Results and follow-up. J Am Coll Cardiol. 2003; 42: 241-245 Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar Despite the demonstrated utility of transcatheter occlusion devices in the vast majority of patients, as many as 8% of patients undergoing percutaneous closure of an ASD or PFO require surgical intervention for device failure or the management of complications. 4 Berdat P.A. Chatterjee T. Pfammatter J.P. et al. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg. 2000; 120: 1034-1039 Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar A wide variety of acute and chronic complications of transcatheter devices has been previously described in the literature, including the presence of a hemodynamically significant residual shunt after device deployment 5 Bohm J. Bittigau K. Kohler F. et al. Surgical removal of atrial septal defect occlusion system-devices. Eur J Cardiothorac Surg. 1997; 12: 869-872 Crossref PubMed Scopus (43) Google Scholar ; recurrent cerebral embolism 6 Z’Brun A. Dai-Do D. Meier B. et al. Recurrent systemic embolism after transcatheter closure of a patent foramen ovale. Eur J Cardiothorac Surg. 1997; 12: 813-814 Crossref PubMed Google Scholar ; device deformation, malposition or embolization 7 Gildein H.P. Daebritz S. Geidel A. et al. Transcatheter closure of atrial septal defects by the “buttoned” device: Complications and need for surgical revision. Pediatr Cardiol. 1997; 18: 328-331 Crossref PubMed Scopus (22) Google Scholar ; thrombus formation 2 Krumsdorf U. Ostermayer S. Billinger K. et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol. 2004; 43: 302-309 Abstract Full Text Full Text PDF PubMed Scopus (485) Google Scholar ; entanglement of the device in a Chiari network 8 Cooke J.C. Gelman J.S. Harper R.W. Chiari network entanglement and herniation into the left atrium by an atrial septal defect occluder device. J Am Soc Echocardiogr. 1999; 12: 601-603 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar ; endocarditis 9 Goldstein J.A. Beardslee M.A. Xu H. et al. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale. Catheter Cardiovasc Interv. 2002; 55: 217-220 Crossref PubMed Scopus (34) Google Scholar ; device-induced mitral regurgitation 7 Gildein H.P. Daebritz S. Geidel A. et al. Transcatheter closure of atrial septal defects by the “buttoned” device: Complications and need for surgical revision. Pediatr Cardiol. 1997; 18: 328-331 Crossref PubMed Scopus (22) Google Scholar ; and cardiac perforation. 4 Berdat P.A. Chatterjee T. Pfammatter J.P. et al. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg. 2000; 120: 1034-1039 Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar In this report, the authors describe the occurrence of acute pericardial tamponade 5 years after implantation of a CardioSEAL septal occluder (Nitinol Medical Technology, Boston, MA) as a result of erosion of a device wire support through the dome of the left atrium (LA) and briefly discuss the perioperative management of the patient.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call